Bridging the COPD awareness gap in marginalized populations: Findings from a multicentre study in Khalilabad, Sant Kabir Nagar, Uttar Pradesh, India
Paper Details
Bridging the COPD awareness gap in marginalized populations: Findings from a multicentre study in Khalilabad, Sant Kabir Nagar, Uttar Pradesh, India
Abstract
Sant Kabir Nagar, a district in Uttar Pradesh, India, faces significant healthcare challenges, particularly in managing Chronic Obstructive Pulmonary Disease (COPD). This study highlights the alarming lack of COPD awareness, with only 3% of patients recognizing their condition, while 54% had no knowledge and 43% refused diagnosis. Major risk factors include biomass fuel exposure (47.8%), agricultural pollution (32%), and smoking (13.4%). Despite global preference for inhalation therapy, only 9% of patients in Khalilabad, Sant Kabir Nagar receive optimal bronchodilator treatment, with 42% relying on oral medications due to cost, misconceptions, and poor accessibility. The “Difficult Doctor, Difficult Patient, and Difficult Treatment” phenomenon further hampers COPD management. Misconceptions about inhalers, financial constraints, and inadequate physician training lead to underdiagnosis and suboptimal treatment. Key recommendations include nationwide awareness campaigns, spirometry training for physicians, and government-led initiatives to promote inhaler use. Subsidizing inhalation therapy could significantly improve adherence and patient outcomes. Immediate action is essential to bridge the COPD treatment gap in Khalilabad, Sant Kabir Nagar. By addressing financial, educational, and medical barriers, policymakers and healthcare professionals can enhance early detection, improve treatment strategies, and ultimately reduce the disease burden, leading to better health outcomes and quality of life for affected individuals.
Asai M, Tanaka T, Kozu R, Kitagawa C, Tabusadani M, Senjyu H. 2015. Effect of a chronic obstructive pulmonary disease (COPD) intervention on COPD awareness in a regional city in Japan. Internal Medicine 54, 163–169. https://doi.org/10.2169/internalmedicine.54.2916
Bayram M, Akgün M. 2017. If you know the enemy and your weapons, you need not fear the management of chronic obstructive pulmonary disease. Turkish Thoracic Journal 18, 100. https://doi.org/10.5152/TurkThoracJ.2017.190917
Buffels J, Degryse J, Heyrman J, Decramer M. 2004. Office spirometry significantly improves early detection of COPD in general practice: The DIDASCO study. Chest 125, 1394–1399.
Cazzola M, Calzetta L, Barnes PJ, et al. 2018. Efficacy and safety profile of xanthines in COPD: A network meta‐analysis. European Respiratory Review 27, 180010. https://doi.org/10.1183/16000617.0010-2018
Eaton T, Withy S, Garrett JE, Mercer J, Whitlock RM, Rea HH. 1999. Spirometry in primary care practice: The importance of quality assurance and the impact of spirometry workshops. Chest 116, 416–423.
GBD 2015 Chronic Respiratory Disease Collaborators. 2017. Global, regional, and national deaths, prevalence, disability‐adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet Respiratory Medicine 5, 691–706. https://doi.org/10.1016/S2213-2600(17)30293-X
Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2019. GOLD 2019 Pocket Guide. Available at: www.goldcopd.org
Gupta D, Agarwal R, Aggarwal AN. 2013. Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP(I) recommendations. Lung India 30, 228–267. https://doi.org/10.4103/0970-2113.116248
Ministry of Health and Family Welfare, Government of India. 2017. National health policy 2017. New Delhi, India. Available at: https://mohfw.gov.in/documents/policy
O’Donnell DE, Aaron S, Bourbeau J. 2003. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease-2003. Canadian Respiratory Journal 10(suppl A), 11A–65A. https://doi.org/10.1155/2003/567598
Pierce R. 2005. Spirometry: An essential clinical measurement. Australian Family Physician 34, 535–539.
Schermer TR, Jacobs JE, Chavannes NH. 2003. Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD). Thorax 58, 861–866.
Tinkelman DG, Price DB, Nordyke RJ, Halbert RJ. 2006. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over. Journal of Asthma 43, 75–80.
Tripathi AP, Shyam, Vishwakarma V, Chaudhary R, Phatak P, Phatak P. 2023. Visible light and chemicals pave a new way in control of fasciolosis: A review. World Journal of Pharmaceutical Research 12(4), 1781–1798.
Tripathi AP, Upadhyay S, Barnwan S, Singh A, Yadav P, Srivastava P. 2023. Hydrological assets and environmental elements mark the fish diversity in wetland of Sant Kabir Nagar, U.P., India. World Journal of Pharmaceutical Research 12(4), 1057–1067.
Yawn BP, Enright PL, Lemanske RF Jr, et al. 2007. Spirometry can be done in family physicians’ offices and alters clinical decisions in management of asthma and COPD. Chest 132, 1162–1168. https://doi.org/10.1378/chest.06-2722
Yıldız F, Bingöl Karakoç G, Ersu Hamutçu R, Yardım N, Ekinci B, Yorgancıoğlu A. 2013. The evaluation of asthma and COPD awareness in Turkey (GARD Turkey Project—National Control Program of Chronic Airway Diseases). Tuberk Toraks 61, 175–182. https://doi.org/10.5578/tt.6207
Anupam Pati Tripathi, Jigyasa Pandey, Sakshi Singh, Smita Pathak, Dinesh Chaudhary, Alfiya Mashii, Farheen Fatima, 2025. Bridging the COPD awareness gap in marginalized populations: Findings from a multicentre study in Khalilabad, Sant Kabir Nagar, Uttar Pradesh, India. J. Biodiv. Environ. Sci., 27(2), 97-108.
Copyright © 2025 by the Authors. This article is an open access article and distributed under the terms and conditions of the Creative Commons Attribution 4.0 (CC BY 4.0) license.